.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
US Department of Justice
Julphar
Accenture
QuintilesIMS
Johnson and Johnson
Chinese Patent Office
McKinsey
McKesson
Deloitte

Generated: September 21, 2017

DrugPatentWatch Database Preview

Betamethasone dipropionate; calcipotriene - Generic Drug Details

« Back to Dashboard

What are the generic sources for betamethasone dipropionate; calcipotriene and what is the scope of betamethasone dipropionate; calcipotriene freedom to operate?

Betamethasone dipropionate; calcipotriene
is the generic ingredient in three branded drugs marketed by Leo Pharma As, Tolmar, and Perrigo Israel, and is included in five NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Betamethasone dipropionate; calcipotriene has seventy-three patent family members in thirty-two countries.

There are sixty-six drug master file entries for betamethasone dipropionate; calcipotriene. One supplier is listed for this compound.

Summary for Generic Name: betamethasone dipropionate; calcipotriene

Tradenames:3
Patents:3
Applicants:3
NDAs:5
Drug Master File Entries: see list66
Suppliers / Packagers: see list1
Clinical Trials: see list207
Drug Prices:see low prices
DailyMed Link:betamethasone dipropionate; calcipotriene at DailyMed

Pharmacology for Ingredient: betamethasone dipropionate; calcipotriene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tolmar
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
betamethasone dipropionate; calcipotriene hydrate
OINTMENT;TOPICAL201615-001Jan 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
SUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Leo Pharma As
ENSTILAR
betamethasone dipropionate; calcipotriene
AEROSOL, FOAM;TOPICAL207589-001Oct 16, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
OINTMENT;TOPICAL021852-001Jan 9, 2006ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Perrigo Israel
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
betamethasone dipropionate; calcipotriene hydrate
OINTMENT;TOPICAL200174-001Dec 12, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
SUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► Subscribe► Subscribe
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
SUSPENSION;TOPICAL022185-001May 9, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Leo Pharma As
ENSTILAR
betamethasone dipropionate; calcipotriene
AEROSOL, FOAM;TOPICAL207589-001Oct 16, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Leo Pharma As
ENSTILAR
betamethasone dipropionate; calcipotriene
AEROSOL, FOAM;TOPICAL207589-001Oct 16, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Leo Pharma As
TACLONEX
betamethasone dipropionate; calcipotriene hydrate
OINTMENT;TOPICAL021852-001Jan 9, 2006ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: betamethasone dipropionate; calcipotriene

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,566,286Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: betamethasone dipropionate; calcipotriene

Country Document Number Estimated Expiration
Cyprus1115991► Subscribe
Singapore185521► Subscribe
Denmark1178808► Subscribe
Japan2002542293► Subscribe
Japan5945268► Subscribe
Yugoslavia75701► Subscribe
MontenegroP39108► Subscribe
Bulgaria65115► Subscribe
European Patent Office2859886► Subscribe
Poland199123► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
McKesson
Teva
Cerilliant
US Army
Queensland Health
Covington
Medtronic
Federal Trade Commission
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot